Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ADCX-020 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on ADCX-020, a putative antibody-drug conjugate (Feb 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ADCX-020 | ADCX020|ADCX 020 | Limited information is currently available on ADCX-020, a putative antibody-drug conjugate (Feb 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07238075 | Phase I | ADCX-020 | ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers | Recruiting | AUS | 0 |